Telecom Healthcare Sector

Voyager Therapeutics

Market Cap: US$181.5m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

DiaMedica Therapeutics

Market Cap: US$180.0m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Perspective Therapeutics

Market Cap: US$178.9m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Utah Medical Products

Market Cap: US$178.2m

Provides medical devices for the healthcare industry worldwide.

Sight Sciences

Market Cap: US$176.8m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Stereotaxis

Market Cap: US$176.3m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

enGene Holdings

Market Cap: US$175.9m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Anika Therapeutics

Market Cap: US$175.5m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Kodiak Sciences

Market Cap: US$175.3m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Y-mAbs Therapeutics

Market Cap: US$174.8m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Quanterix

Market Cap: US$174.7m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Inhibrx Biosciences

Market Cap: US$174.0m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Eledon Pharmaceuticals

Market Cap: US$173.1m

Operates as a clinical stage biotechnology company.

Liminatus Pharma

Market Cap: US$172.5m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

ProQR Therapeutics

Market Cap: US$171.5m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Spectral Medical

Market Cap: CA$239.5m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

INmune Bio

Market Cap: US$169.2m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

AVITA Medical

Market Cap: US$168.4m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Avacta Group

Market Cap: UK£126.5m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

TuHURA Biosciences

Market Cap: US$167.7m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

ADC Therapeutics

Market Cap: US$167.6m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

LENSAR

Market Cap: US$166.4m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

Organigram Global

Market Cap: CA$231.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Atlantic International

Market Cap: US$165.4m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

TriSalus Life Sciences

Market Cap: US$164.9m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.

Tango Therapeutics

Market Cap: US$164.8m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Journey Medical

Market Cap: US$164.0m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Electromed

Market Cap: US$163.9m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Accuray

Market Cap: US$163.8m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

AFT Pharmaceuticals

Market Cap: NZ$277.9m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Development Technologies

Market Cap: US$163.2m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Puma Biotechnology

Market Cap: US$162.8m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

hVIVO

Market Cap: UK£122.5m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

CVRx

Market Cap: US$161.4m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.